Genprex Inc (GNPX) has released an update to notify the public and investors about corporate charter and bylaws modifications.
Genprex, Inc. has announced a one-for-forty reverse stock split of its common stock, effective at 12:01 a.m. Eastern Time on February 2, 2024, after filing a Certificate of Amendment with the State of Delaware on January 31, 2024. The stock will trade on an adjusted basis from the market opening on February 2, 2024, with a new CUSIP number 372446-203. The adjustment will convert every forty shares of existing common stock into one share without changing the par value or altering stockholders’ percentage interests, except for rounding fractional shares up to the next whole share. All securities related to the common stock will also be adjusted accordingly. This follows the Board’s decision on January 19, 2024, which was authorized by stockholders at a special meeting held on December 14, 2023.
For further insights into GNPX corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.
